BARINTHUS BIOTHERAPEUTICS PLC - AMERICAN DEPOSITAR

Vaccitech Announces Publication of Second Phase 1 Clinical Trial Results of ChAdOx1 Vaccine in Development for the MERS Coronavirus

04 Nov 2021 03:00:00 By Nasdaq GlobeNewswire

Vaccitech Announces Data Presentations at AASLD’s Liver Meeting® 2021

18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Vaccitech to Present an Update on Its Chronic HBV Infection Immunotherapeutic Program at The World Vaccine Congress Europe

13 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Vaccitech to Present at Upcoming September Investor conferences

09 Sep 2021 07:00:02 By Nasdaq GlobeNewswire

Vaccitech Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

12 Aug 2021 07:00:02 By Nasdaq GlobeNewswire

Vaccitech to Present at the William Blair Biotech Focus Conference 2021

08 Jul 2021 07:00:00 By Nasdaq GlobeNewswire

Vaccitech Reports First Quarter 2021 Financial Results and Recent Corporate Developments

14 Jun 2021 16:49:00 By Nasdaq GlobeNewswire

Vaccitech to Present at the Jefferies Virtual Healthcare Conference

01 Jun 2021 07:00:02 By Nasdaq GlobeNewswire

Vaccitech Announces Closing of $110.5 Million Initial Public Offering

04 May 2021 16:07:46 By Nasdaq GlobeNewswire

Vaccitech Announces Pricing of Initial Public Offering

29 Apr 2021 17:49:41 By Nasdaq GlobeNewswire